The North America Transcriptomics Market would witness market growth of 6.9% CAGR during the forecast period (2021-2027).
Technological improvements and a surge in research grants from various institutes are two reasons that are expected to propel the transcriptomics market during the forecasting period. Moreover, the potential for RNAs to be used as diagnostic biomarkers and predictors of treatment response is the key industry trend. Previously, transcriptomics applications were limited to basic gene expression profiling and other research applications like determining the amount of RNA in a biological sample and studying gene expression. Other more prominent transcriptome uses are reported only after the simplification of transcriptomics technologies, reduction in technological costs, and increased awareness of transcriptomics technologies among both scientific intelligentsia and the general public.
The rapid development of structure-based medication designs, increased focus on transcriptomics research, and significant investment in biopharmaceutical research and development are the key trends of the regional market. In addition, rising funding in pharmaceutical research and development by the governments of different regional countries would create a conducive environment for the regional market players. North America, particularly the United States, is home to the majority of key players of transcriptomic systems, platforms, equipment, and technologies. Rebus Biosystems, for example, debuted its spatial transcriptomics analysis platform "spatial omics" system in 2021, which is aimed to allow researchers to examine the output of individual cells across tissue samples in more detail.
North American countries have experienced and continue to incur a major economic and healthcare burden as a result of COVID-19's high transmission rate and lack of therapy. The sale of reagents and consumables used in transcriptomics analysis has decreased as a result of the closure of research and academic institutes.
The US market dominated the North America Transcriptomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $2,674 million by 2027. The Canada market is poised to grow at a CAGR of 9.4% during (2021 - 2027). Additionally, The Mexico market would exhibit a CAGR of 8.4% during (2021 - 2027).
Based on Technology, the market is segmented into q PCR, Microarrays, and Sequencing Technology. Based on Application, the market is segmented into Drug Discovery, Diagnostics & Disease Profiling, and Others. Based on Component, the market is segmented into Consumables, Instruments, Software, and Services. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Transcriptomics Market is Estimated to reach $9.4 Billion by 2027, at a CAGR of 7.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Promega Corporation, General Electric (GE) Co., Merck & Co., Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Qiagen N.V.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- q PCR
- Microarrays
- Sequencing Technology
By Application
- Drug Discovery
- Diagnostics & Disease Profiling
- Others
By Component
- Consumables
- Instruments
- Software
- Services
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Fluidigm Corporation
- Promega Corporation
- General Electric (GE) Co.
- Merck & Co., Inc.
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Qiagen N.V.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Transcriptomics Market, by Technology
1.4.2 North America Transcriptomics Market, by Application
1.4.3 North America Transcriptomics Market, by Component
1.4.4 North America Transcriptomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan – 2021, Apr) Leading Players
3.3.3 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar – 2021, Nov) Leading Players
Chapter 4. North America Transcriptomics Market by Technology
4.1 North America q PCR Market by Country
4.2 North America Microarrays Market by Country
4.3 North America Sequencing Technology Market by Country
Chapter 5. North America Transcriptomics Market by Application
5.1 North America Drug Discovery Market by Country
5.2 North America Diagnostics & Disease Profiling Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Transcriptomics Market by Component
6.1 North America Consumables Market by Country
6.2 North America Instruments Market by Country
6.3 North America Software Market by Country
6.4 North America Services Market by Country
Chapter 7. North America Transcriptomics Market by Country
7.1 US Transcriptomics Market
7.1.1 US Transcriptomics Market by Technology
7.1.2 US Transcriptomics Market by Application
7.1.3 US Transcriptomics Market by Component
7.2 Canada Transcriptomics Market
7.2.1 Canada Transcriptomics Market by Technology
7.2.2 Canada Transcriptomics Market by Application
7.2.3 Canada Transcriptomics Market by Component
7.3 Mexico Transcriptomics Market
7.3.1 Mexico Transcriptomics Market by Technology
7.3.2 Mexico Transcriptomics Market by Application
7.3.3 Mexico Transcriptomics Market by Component
7.4 Rest of North America Transcriptomics Market
7.4.1 Rest of North America Transcriptomics Market by Technology
7.4.2 Rest of North America Transcriptomics Market by Application
7.4.3 Rest of North America Transcriptomics Market by Component
Chapter 8. Company Profiles
8.1 Fluidigm Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.2 Promega Corporation
8.2.1 Company Overview
8.3 General Electric (GE) Co. (GE Healthcare)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Merck & Co., Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Thermo Fisher Scientific, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Illumina, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.8 Agilent Technologies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Qiagen N.V.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Acquisition and Mergers:
TABLE 1 North America Transcriptomics Market, 2017 - 2020, USD Million
TABLE 2 North America Transcriptomics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Transcriptomics Market
TABLE 4 Product Launches And Product Expansions – Transcriptomics Market
TABLE 5 Acquisition and Mergers– Transcriptomics Market
TABLE 6 North America Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 7 North America Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 8 North America q PCR Market by Country, 2017 - 2020, USD Million
TABLE 9 North America q PCR Market by Country, 2021 - 2027, USD Million
TABLE 10 North America Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 11 North America Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 12 North America Sequencing Technology Market by Country, 2017 - 2020, USD Million
TABLE 13 North America Sequencing Technology Market by Country, 2021 - 2027, USD Million
TABLE 14 North America Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 15 North America Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 16 North America Drug Discovery Market by Country, 2017 - 2020, USD Million
TABLE 17 North America Drug Discovery Market by Country, 2021 - 2027, USD Million
TABLE 18 North America Diagnostics & Disease Profiling Market by Country, 2017 - 2020, USD Million
TABLE 19 North America Diagnostics & Disease Profiling Market by Country, 2021 - 2027, USD Million
TABLE 20 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 21 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 22 North America Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 23 North America Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 24 North America CONSUMABLES MARKET by Country, 2017 - 2020, USD Million
TABLE 25 North America CONSUMABLES MARKET by Country, 2021 - 2027, USD Million
TABLE 26 North America INSTRUMENTS MARKET by Country, 2017 - 2020, USD Million
TABLE 27 North America INSTRUMENTS MARKET by Country, 2021 - 2027, USD Million
TABLE 28 North America SOFTWARE MARKET by Country, 2017 - 2020, USD Million
TABLE 29 North America Software Market by Country, 2021 - 2027, USD Million
TABLE 30 North America Services Market by Country, 2017 - 2020, USD Million
TABLE 31 North America Services Market by Country, 2021 - 2027, USD Million
TABLE 32 North America Transcriptomics Market by Country, 2017 - 2020, USD Million
TABLE 33 North America Transcriptomics Market by Country, 2021 - 2027, USD Million
TABLE 34 US Transcriptomics Market, 2017 - 2020, USD Million
TABLE 35 US Transcriptomics Market, 2021 - 2027, USD Million
TABLE 36 US Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 37 US Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 38 US Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 39 US Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 40 US Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 41 US Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 42 Canada Transcriptomics Market, 2017 - 2020, USD Million
TABLE 43 Canada Transcriptomics Market, 2021 - 2027, USD Million
TABLE 44 Canada Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 45 Canada Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 46 Canada Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 47 Canada Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 48 Canada Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 49 Canada Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 50 Mexico Transcriptomics Market, 2017 - 2020, USD Million
TABLE 51 Mexico Transcriptomics Market, 2021 - 2027, USD Million
TABLE 52 Mexico Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 53 Mexico Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 54 Mexico Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 55 Mexico Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 56 Mexico Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 57 Mexico Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 58 Rest of North America Transcriptomics Market, 2017 - 2020, USD Million
TABLE 59 Rest of North America Transcriptomics Market, 2021 - 2027, USD Million
TABLE 60 Rest of North America Transcriptomics Market by Technology, 2017 - 2020, USD Million
TABLE 61 Rest of North America Transcriptomics Market by Technology, 2021 - 2027, USD Million
TABLE 62 Rest of North America Transcriptomics Market by Application, 2017 - 2020, USD Million
TABLE 63 Rest of North America Transcriptomics Market by Application, 2021 - 2027, USD Million
TABLE 64 Rest of North America Transcriptomics Market by Component, 2017 - 2020, USD Million
TABLE 65 Rest of North America Transcriptomics Market by Component, 2021 - 2027, USD Million
TABLE 66 Key Information – Fluidigm Corporation
TABLE 67 key Information – Promega Corporation
TABLE 68 Key Information – General Electric (GE) Co.
TABLE 69 KEY INFORMATION - MERCK & CO., INC.
TABLE 70 Key Information – Thermo Fisher Scientific, Inc.
TABLE 71 key information – Illumina, Inc.
TABLE 72 Key Information – Bio-Rad Laboratories, Inc.
TABLE 73 key Information – Agilent Technologies, Inc.
TABLE 74 key information – F. Hoffmann-La Roche Ltd.
TABLE 75 Key Information – Qiagen N.V.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan – 2021, Apr) Leading Players
FIG 5 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar – 2021, Nov) Leading Players
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Bio-Rad Laboratories, Inc.
FIG 8 Recent strategies and developments: Qiagen N.V.